{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:05:41Z","timestamp":1791201941307,"version":"4.2.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12350-023-03205-7","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T13:05:45Z","timestamp":1677589545000},"page":"1810-1821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Detection of sympathetic denervation defects in Fabry disease by hybrid [11C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance"],"prefix":"10.1016","volume":"30","author":[{"given":"Constantin","family":"Gatterer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wollenweber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysoula","family":"Vraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gere","family":"Sunder-Plassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Loewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senta","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Beitzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-023-03205-7_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry\u2019s disease","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-023-03205-7_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijcard.2017.06.079","article-title":"Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy","volume":"248","author":"Frustaci","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib3","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.3390\/ijms22094434","article-title":"Fabry disease and the heart: A comprehensive review","volume":"22","author":"Azevedo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s12350-023-03205-7_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: Changing pattern of causes of death in FOS-Fabry Outcome Survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J Med Genet"},{"key":"10.1007\/s12350-023-03205-7_bib5","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00259-017-3778-1","article-title":"Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson\u2013Fabry disease","volume":"44","author":"Imbriaco","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-023-03205-7_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00259-015-3036-3","article-title":"First experience of simultaneous PET\/MRI for the early detection of cardiac involvement in patients with Anderson\u2013Fabry disease","volume":"42","author":"Nappi","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-023-03205-7_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12350-019-01734-8","article-title":"Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson\u2013Fabry disease","volume":"28","author":"Spinelli","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib8","unstructured":"Acampa W, D\u2019Antonio A, Imbriaco M, Pisani A, Cuocolo A. Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology? J Nucl Cardiol 2020."},{"key":"10.1007\/s12350-023-03205-7_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/ehjci\/jez039","article-title":"Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson\u2013Fabry disease: AFFINITY study group","volume":"20","author":"Imbriaco","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-023-03205-7_bib10","article-title":"Myocardial Storage, inflammation, and cardiac phenotype in fabry disease after one year of enzyme replacement","volume":"12","author":"Nordin","year":"2019","journal-title":"Therapy"},{"key":"10.1007\/s12350-023-03205-7_bib11","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1253\/circj.CJ-16-0690","article-title":"Focal Reduction in cardiac (123)I-metaiodobenzylguanidine uptake in patients with Anderson\u2013Fabry disease","volume":"80","author":"Yamamoto","year":"2016","journal-title":"Circ J"},{"key":"10.1007\/s12350-023-03205-7_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10545-005-0563-2","article-title":"Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease","volume":"28","author":"Kalliokoski","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1007\/s12350-023-03205-7_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00259-015-3273-5","article-title":"Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by 123I-meta-iodobenzylguanidine imaging in Anderson\u2013Fabry disease","volume":"43","author":"Spinelli","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-023-03205-7_bib14","first-page":"1368","article-title":"Regional 11C-hydroxyephedrine retention in hibernating myocardium: Chronic inhomogeneity of sympathetic innervation in the absence of infarction","volume":"46","author":"Luisi","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-023-03205-7_bib15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12350-019-01787-9","article-title":"Anderson\u2013Fabry disease: Worthy to in-SPECT the nerves?","volume":"28","author":"Massalha","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1007\/s12350-023-03205-7_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12968-020-00683-3","article-title":"Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update","volume":"22","author":"Kawel-Boehm","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-023-03205-7_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1148\/radiol.13121038","article-title":"PET\/MR Imaging: Technical aspects and potential clinical applications","volume":"267","author":"Torigian","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1007\/s12350-023-03205-7_bib18","first-page":"1","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagi","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-023-03205-7_bib19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s002590050301","article-title":"Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography","volume":"25","author":"Nekolla","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1007\/s12350-023-03205-7_bib20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0735-1097(93)90553-D","article-title":"Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography","volume":"22","author":"Allman","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib21","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.CIR.99.14.1866","article-title":"Serial assessment of sympathetic reinnervation after orthotopic heart transplantation: A longitudinal study using PET and C-11 hydroxyephedrine","volume":"99","author":"Bengel","year":"1999","journal-title":"Circulation"},{"key":"10.1007\/s12350-023-03205-7_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115185","article-title":"Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography","volume":"87","author":"Schwaiger","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1007\/s12350-023-03205-7_bib23","first-page":"262","article-title":"Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: An analysis using carbon-11 hydroxyephedrine and positron emission tomography","volume":"81","author":"Hartmann","year":"1999","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijcard.2019.07.041","article-title":"Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries","volume":"299","author":"Possner","year":"2020","journal-title":"Int J cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1007\/s12350-023-03205-7_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson\u2013Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"key":"10.1007\/s12350-023-03205-7_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: A comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-023-03205-7_bib28","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00259-017-3760-y","article-title":"Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: (11)C-hydroxyephedrine PET study","volume":"44","author":"Aikawa","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-023-03205-7_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","article-title":"Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy","volume":"63","author":"Fallavollita","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2012.02.070","article-title":"Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation","volume":"60","author":"Klem","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib31","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.jacc.2009.12.066","article-title":"Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients","volume":"55","author":"Boogers","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib32","doi-asserted-by":"crossref","first-page":"f153","DOI":"10.1093\/europace\/eux261","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: A systematic review of risk factors in clinical practice","volume":"20","author":"Baig","year":"2018","journal-title":"EP Europace"},{"key":"10.1007\/s12350-023-03205-7_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1148\/radiol.2019191385","article-title":"Left ventricular hypertrophy and late gadolinium enhancement at cardiac MRI are associated with adverse cardiac events in Fabry disease","volume":"294","author":"Hanneman","year":"2020","journal-title":"Radiology"},{"key":"10.1007\/s12350-023-03205-7_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/heartjnl-2018-313699","article-title":"Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease","volume":"105","author":"Vijapurapu","year":"2019","journal-title":"Heart"},{"key":"10.1007\/s12350-023-03205-7_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008534","article-title":"Imaging of myocardial catecholamine uptake","volume":"11","author":"Bengel","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-023-03205-7_bib36","article-title":"First-in-human studies of [(18)F] fluorohydroxyphenethylguanidines","volume":"11","author":"Raffel","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-023-03205-7_bib37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2967\/jnumed.115.158493","article-title":"Retention kinetics of the 18F-labeled sympathetic nerve PET Tracer LMI1195: Comparison with 11C-hydroxyephedrine and 123I-MIBG","volume":"56","author":"Werner","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-023-03205-7_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjcard.2012.08.055","article-title":"Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with Anderson\u2013Fabry disease","volume":"111","author":"Coats","year":"2013","journal-title":"Heart Ame J Cardiol"},{"key":"10.1007\/s12350-023-03205-7_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002839","article-title":"High-sensitivity troponin: A clinical blood biomarker for staging cardiomyopathy in fabry disease","volume":"5","author":"Seydelmann","year":"2016","journal-title":"J Am Heart Assoc"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-023-03205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-023-03205-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-023-03205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:13:09Z","timestamp":1761027189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358124000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1071358124000989"],"URL":"https:\/\/doi.org\/10.1007\/s12350-023-03205-7","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of sympathetic denervation defects in Fabry disease by hybrid [11C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-023-03205-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by ELSEVIER INC. on behalf of American Society of Nuclear Cardiology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}